Stem Cell Therapy finalizes merger with South Korean firm

02/1/2010 | American City Business Journals

Stem Cell Therapy International has completed its merger with South Korean firm Histostem in a deal that will allow it to run Histostem as its wholly owned unit. Stem Cell Therapy, a provider of biological supplies containing new stem cell product lines, plans to operate under the name AmStem.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ